首页> Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico> Development and validation of a cuproptosis-related gene signature for predicting prognosis and drug sensitivity in gastric cancer.

Development and validation of a cuproptosis-related gene signature for predicting prognosis and drug sensitivity in gastric cancer.

导出 LinkOut

翻译打印收藏纠错

第一作者： Hongxin,Huang

第一单位： Gastric Cancer Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, 210029, People's Republic of China. hongxinhuang@njmu.edu.cn.;Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, 210029, People's Republic of China. hongxinhuang@njmu.edu.cn.

作者： Hongxin,Huang ^[1] ; Funing,Zhang ^[2] ; Zetian,Chen ^[2] ; Jihuan,Wang ^[2] ; Yifan,Zou ^[2] ; Weizhi,Wang ^[2] ; Zekuan,Xu ^[3]

作者单位： Gastric Cancer Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, 210029, People's Republic of China. hongxinhuang@njmu.edu.cn.;Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, 210029, People's Republic of China. hongxinhuang@njmu.edu.cn. ^[1] Gastric Cancer Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, 210029, People's Republic of China.;Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, 210029, People's Republic of China. ^[2] Gastric Cancer Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, 210029, People's Republic of China. xuzekuan@njmu.edu.cn.;Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, 210029, People's Republic of China. xuzekuan@njmu.edu.cn.;Institute for Gastric Cancer Research, Nanjing Medical University, Nanjing, Jiangsu, 211166, People's Republic of China. xuzekuan@njmu.edu.cn.;Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing Medical University, Nanjing, Jiangsu, 211166, People's Republic of China. xuzekuan@njmu.edu.cn. ^[3]

关键词 Cuproptosis Drug response Gastric cancer Prognosis Survival prediction

DOI 10.1007/s12094-025-04132-4

PMID 41296174

发布时间 2025-11-26

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交